November 9, 2015 - November 10, 2015
Veterans Health Administration National Conference Center
2011 Crystal Drive, 1st floor Conference Center
Crystal City, VA 22202
Agenda
November 9, 2015
| Time | Agenda Item | Presenter |
|---|---|---|
| 07:30 am (30 min) |
Doors Open | Open to the Public |
| 08:00 am (10 min) |
Call to Order | Jay Menitove, MD Committee Chair |
| 08:10 am (5 min) |
Roll Call | James Berger Executive Secretary |
Committee Business
| Time | Agenda Item | Presenter |
|---|---|---|
| 08:15 am (5 min) |
New Member Welcome and Retiring Member Recognition | Jay Menitove, MD Committee Chair |
| 08:20 am (10 min) |
Acting Assistant Secretary for Health’s Charge to the Committee | Karen B. DeSalvo, MD, MPH, MSc Acting Assistant Secretary for Health |
Hospital Perspective
| Time | Agenda Item | Presenter |
|---|---|---|
| 10:25 am (30 min) |
Assurance Value of Blood | Lynne Uhl, MD Chief, Division of Laboratory and Transfusion Medicine Beth Israel Deaconess Medical Center, Boston, MA |
| 10:55 am (30 min) |
Risk Management in Hospitals | Zbigniew “Ziggy” M. Szczepiorkowski, MD, PhD, FACP Section Chief, Clinical Pathology, Dartmouth-Hitchcock Medical Center |
| 11:25 am (25 min) |
Committee Questions and Discussion |
Updates for Committee
| Time | Agenda Item | Presenter |
|---|---|---|
| 11:50 am (10 min) |
Report on the Symposium on the Accessibility and Development of Tissue Products for Emergency Preparedness | Timothy L. Pruett, MD John S Najarian Clinical Chair Professor of Surgery and Internal Medicine, University of Minnesota |
| 12:00 pm | Lunch • 1 hour |
Budget Impact Perspective
| Time | Agenda Item | Presenter |
|---|---|---|
| 01:00 pm (45 min) |
Challenges for Adoption of New Safety Initiatives with Current Blood Bank Economics | Brian Custer, PhD, MPH Associate Director Blood Systems Research Institute |
| 01:45 pm (30 min) |
Medicare Hospital Reimbursement for Transfusion Services | Miriam A. Markowitz, MSc Chief Executive Officer AABB |
Purchasers and Payers Perspective
| Time | Agenda Item | Presenter |
|---|---|---|
| 02:15 pm (30 min) |
Dignity Health Perspective | Kelley Moore Senior Director, Contract Management, Supply & Service Resource Management Dignity Health Craig Kielbowicz Lab Product Line Administrator Dignity Health |
| 02:45 pm | Break • 10 min | |
| 02:55 pm (30 min) |
Premier, Inc. Perspective | Michael Maguire, MPA Vice President, Strategic Sourcing Premier, Inc. |
| 03:25 pm (35 min) |
Committee Questions and Discussion | |
| 04:00 pm | Adjournment | Jay Menitove, MD Committee Chair |
November 10, 2015
| Time | Agenda Item | Presenter |
|---|---|---|
| 08:00 am (25 min) |
Doors Open | Open to the Public |
| 08:25 am (10 min) |
Call to Order | Jay Menitove, MD Committee Chair |
| 08:35 am (5 min) |
Roll Call | James Berger Executive Secretary |
Updates for Committee
| Time | Agenda Item | Presenter |
|---|---|---|
| 08:40 am (15 min) |
Subcommittee on Blood System Sustainability | Jay Menitove, MD Committee Chair |
| 08:55 am (15 min) |
Summary of May 13th 2015 Blood Product Advisory Committee Meeting: Strategies for Implementation of Antibody and Nucleic Acid- based Testing for Babesia microti in Blood Donations | Hira L. Nakhasi, PhD Director, Division of Emerging and Transfusion Transmitted Diseases Office of Blood Research and Review, Center for Biologics Evaluation and Research Food and Drug Administration |
| 09:10 am (20 min) |
Update on April 2015 ACBTSA Tissue Tracking and Traceability Recommendations | CAPT Laura M. St. Martin, MD, MPH CGTP Team Lead, Division of Human Tissues Food and Drug Administration Frank S. Wilton, CAE, IOM President and Chief Executive Officer American Association of Tissue Banks |
Purchasers and Payers Perspective (cont'd)
| Time | Agenda Item | Presenter |
|---|---|---|
| 09:30 am (30 min) |
Medicare Payment for Pathogen Reduced Blood Products | Marc Hartstein Director, Hospital and Ambulatory Policy Group Centers for Medicare and Medicaid Services |
| 10:00 am | Break • 10 min |
Public Comment and Committee Discussion
| Time | Agenda Item | Presenter |
|---|---|---|
| 10:10 am (65 min) |
Committee Discussion and Recommendations | |
| 11:15 am (30 min) |
Public Comment Period | |
| 11:45 am | Lunch • 1 hour | |
| 12:45 pm (90 min) |
Committee Discussion and Recommendations | |
| 2:15 pm (10 min) |
Closing Comments | Jay Menitove, MD Committee Chair |
| 2:25 pm | Adjournment | Jay Menitove, MD Committee Chair |
